Investigation of Functional Brain Features in Women with Migraine
NCT06470958 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-11-04
Summary
This study aims to investigate whether the functional alterations in the brain of individuals with migraine appear before the peripheral vascular changes. This will be investigated using functional and structural neuroimaging in individuals with spontaneous menstually-related migraine.
Conditions
Sponsors & Collaborators
-
Danish Headache Center
lead OTHER
Principal Investigators
-
Faisal Mohammad Amin · Danish Headache Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-10
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
Functional MRI (fMRI) in CGRP Induced Migraine
NCT00363532 ·Status: COMPLETED ·Phase: NA
-
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622 ·Status: COMPLETED
-
Oxygenation and Perfusion in Patients With Acute Migraine Attacks
NCT03536936 ·Status: COMPLETED
-
Registry for Migraine - Clinical Core
NCT04603976 ·Status: UNKNOWN ·Phase: PHASE4
-
Imaging the Migraine Brain Pre- and Post-Erenumab
NCT03773562 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
NCT04299958 ·Status: COMPLETED
-
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
NCT06659120 ·Status: RECRUITING
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients
NCT03977649 ·Status: COMPLETED ·Phase: PHASE4
-
Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
NCT01896167 ·Status: COMPLETED ·Phase: NA
-
Nutritional Intervention in Migraine
NCT02703129 ·Status: COMPLETED ·Phase: NA
-
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
NCT03481400 ·Status: UNKNOWN ·Phase: NA
-
Physiopathology, Diagnosis and Therapy of Primary Cephalalgia and Adaptive Disorders
NCT04696510 ·Status: COMPLETED
-
Familial and Environmental Factors Behind Migraine
NCT04356079 ·Status: UNKNOWN
-
Prevalence of Chronic Abdominal Pain in Migraneurs
NCT05086562 ·Status: UNKNOWN
-
Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
NCT02309606 ·Status: COMPLETED
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
Clinical Characteristics and Pathophysiology of Post-Traumatic Headache
NCT03791515 ·Status: COMPLETED ·Phase: NA
-
Frovatriptan and Menstrual Migraine
NCT01114711 ·Status: TERMINATED
-
Prevalence and Determinants of Migraine Among Headache Patients
NCT07038499 ·Status: NOT_YET_RECRUITING
-
HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs
NCT06155123 ·Status: RECRUITING
-
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
NCT04592952 ·Status: UNKNOWN ·Phase: PHASE4
-
Understanding the Pathophysiology of Migraine Pain
NCT03026101 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a New Treatment for Migraine Attacks
NCT01880671 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks
NCT02583581 ·Status: UNKNOWN ·Phase: NA